LAURA Moorenead's of Angela Davis's book 'Women, Race and Class' (SC no 272) needs challenging. What Laura objects to is that Davis appears counterpose for women's rights to the struggle black and the struggle Working people plying 'conflicting interests'. And even implying 'that the struggle equality can be advanced at the working people'. Also that the book 'leaves us nowhere to go.
Davis doesn't "imply' conflicting interests in her histort of women's suffrage and the black She gives us The lessons are clear, alliances OCLWCCH most oppressed can never suborommate ner struggle to that of a relatively c gro with leadership movement seeking alances wit te runng class, as Laura But in criticising Davis surely agree with her that ing class WORCH WCIC fundamentally LACH men by une class exploitation and racist which did behaviour While thei ICCUCU cranenced. enemy was the boss. responsible the unbearable worksexist discrimination on the job' (p142).
'ignoring downplaving the struggle for can't it. Her view or women's strug He is nawca by renance upo he Communist Party (USA THE recent hysteria of the Tory press and the majority of MPs over the GLC's invitation to almost impossible. Even to question Britain's But I believe Davis is saying 200ON OL TaCIST positions by a section of the was an evil thai black people. Severe Finally, leave nowhere to go? A little severe this. The di scussion or socialisation useful, HOUSCWOrK SUICLY ana lac ICruLaLon LIL "wages for housework' posiby examination of black workers novel, to me at least.
feeling that Laura S ICVICW conceals unpreparedness face the fact that the ability of the rul he progressive CADI COCU through -I Cal Lollary or tansanon among women, blacks and workers. STEPHEN BELL Roath, Cardiff ••.
The same methods are deployed on the A NUMBER of groups concerned women and health have formed an ad hoc committee to oppose a long term license for the contraceptive injection Depo Provera.
We are seriously concerned that side effects of Depo unimportant, women are bein pressured to after childbirth an ubell given WITHOU thei concerned that the available Further. research on the drug wa lone independently and i ing interpreted to prove drug is safe; we do not believe that proot actuay exist We are seeking information or from health workers on uses weneed to 1C0 -lect this information befor 15 March 1983 to present to the public hearing British licensing authority has refused a long term license to Depo Provera and mat decision te hope ing work alongside other who WHICHC LU oooose a lone temu cense an ate meera mean LC00 • Provera would occome available other res as a first-choice method anticipate that a advertising campaign b the would courage doctors to recommend the drug to women as at easy' choice doctor, too) wher contraceptive methods might do ustas wer oreven Deuter. ou first meeting therefore decio ed we could only support -month injection only) witl added restrictions on its al WHOEmCG COnSCHL DrO cedure and onlow-up on al women using it.
Because a small number of we reel we cannor support d Depo Provera However, , with a short-term Depo Provera would available those women, as it is at the moment, and with added safeguards we nose abuses can be reauced to a minimum.
We have serious doubts about LIC SaICLy of al hor -contraceDnon. Depo Provera is merely one in long line of methods now be ing tested which disrupts a woman's to orcenancy. we ocueye mal.
come on the market unques these • as are alower to tioned, future research methods affec women's health WIl never be The manutac Lurcis or coo rrovera nave a profit to lose because women are question ing the need for it; we believe women nave a great deal to gain.
contact the Co. ordinating Group on Depa Provera c/o 374 Grays Inn London WC1X 8BB Tel: 01-278 0153
----- pull-quotes -----
new initiatives needed
ing class to subveri enemient is
hen the for
themselves unable to use other methods